By Dr. Mercola Only nine days away from his swearing-in as president, Donald Trump held his first press conference since the election and announced that the pharmaceutical industry was "getting away with murder" and that during his presidency he would do something about high drug prices with more competitive bidding for federal contracts. His remarks sent drug stocks into a sudden nosedive.1 As noted by Brad Loncar, manager of Loncar Cancer Immunotherapy ETF: "When somebody that high-profile says something that negative, people do not want to invest in it." According to Reuters:2 "Trump's campaign platform included allowing the Medicare healthcare program to negotiate with pharmaceutical companies, which the law currently prohibits. He has also discussed making it easier to import drugs at cheaper prices. 'We are going to start bidding. We are going to save billions of dollars over time,' Trump said." Trump's comments came only one day after Robert F. Kennedy Jr. told reporters that T
http://articles.mercola.com/sites/articles/archive/2017/01/24/new-vaccine-safety-review-panel.aspx
No comments:
Post a Comment